Sana Biotechnology Files Definitive Proxy Statement

TL;DR

Sana Bio (SANA) proxy filed - shareholders vote June 5th on board & pay.

AI Summary

Sana Biotechnology, Inc. filed its definitive proxy statement (DEF 14A) on April 25, 2025, for its annual meeting of stockholders scheduled for June 5, 2025. The filing details information related to the company's governance, executive compensation, and proposals to be voted on by shareholders. Sana Biotechnology, Inc. is a biotechnology company focused on developing engineered cells for therapeutic purposes.

Why It Matters

This filing provides shareholders with crucial information to make informed decisions on company matters, including director elections and executive compensation, impacting the company's future direction and governance.

Risk Assessment

Risk Level: medium — Proxy statements are routine filings, but the specific proposals and the company's financial health can introduce medium risk depending on shareholder sentiment and potential changes in governance or strategy.

Key Players & Entities

• Sana Biotechnology, Inc. (company) — Registrant
• 0001770121 (company) — Central Index Key
• 20250425 (date) — Filing Date
• 20250605 (date) — Meeting Date

FAQ

From the Filing

0001193125-25-094656.txt : 20250425 0001193125-25-094656.hdr.sgml : 20250425 20250425060811 ACCESSION NUMBER: 0001193125-25-094656 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250605 FILED AS OF DATE: 20250425 DATE AS OF CHANGE: 20250425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39941 FILM NUMBER: 25869753 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98102 DEF 14A 1 d886889ddef14a.htm DEF 14A DEF 14A DEF 14A false 0001770121 0001770121 2024-01-01 2024-12-31     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )     Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box:   ☐ Preliminary Proxy Statement   ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))   ☒ Definitive Proxy Statement   ☐ Definitive Additional Materials   ☐ Soliciting Material under §240.14a-12 SANA BIOTECHNOLOGY, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):   ☒ No fee required.   ☐ Fee paid previously with preliminary materials.   ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11       SANA BIOTECHNOLOGY, INC. 188 East Blaine Street, Suite 400 Seattle, Washington 98102 NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 5, 2025 Notice is hereby given that the 2025 Annual Meeting of Stockholders (Annual Meeting) of Sana Biotechnology, Inc. will be held at 9:00 a.m., Pacific Time, on June 5, 2025. To facilitate stockholder attendance and participation and to provide a consistent experience for all stockholders, regardless of location, the Annual Meeting will be a virtual meeting conducted via live audio webcast. You will not be able to attend the Annual Meeting physically. To be admitted to and participate in the Annual Meeting, you must register by 2:00 p.m., Pacific Time, on June 4, 2025, at www.proxydocs.com/SANA . As part of the registration process, you will be required to enter the control number included on your Notice of Internet Availability of Proxy Materials (Notice) or on your proxy card or voter instruction form, as applicable, if you are receiving a printed copy of our proxy materials. After completing your registration, you will receive further instructions via email prior to the start of the Annual Meeting, including a unique link that will allow you to access the Annual Meeting. Please see the “General Information” section of the attached proxy statement for more details regarding the logistics of the virtual Annual Meeting, including the ability of stockholders to submit questions prior to and during the Annual Meeting and technical details related to accessing the virtual platform. If we elect to adjourn the Annual Meeting to another time or place, including due to a technical issue that occurs prior to or during the Annual Meeting, we may do so by announcing the time, date, and location (including the method of access and communication) of the adjourned meeting at the Annual Meeting or by displaying su